https://stock.noler.com/us/stock/mirati-therapeutics-inc https://stock.noler.com/us/stock/mirati-therapeutics-inc/accounts-payable https://stock.noler.com/us/stock/mirati-therapeutics-inc/accounts-payable-and-accrued-liabilities-current https://stock.noler.com/us/stock/mirati-therapeutics-inc/accounts-payable-and-accrued-liabilities-noncurrent https://stock.noler.com/us/stock/mirati-therapeutics-inc/accounts-payable-current-and-noncurrent https://stock.noler.com/us/stock/mirati-therapeutics-inc/accounts-receivable https://stock.noler.com/us/stock/mirati-therapeutics-inc/accrued-liabilities-current https://stock.noler.com/us/stock/mirati-therapeutics-inc/accrued-liabilities-current-and-noncurrent https://stock.noler.com/us/stock/mirati-therapeutics-inc/accrued-rent-current https://stock.noler.com/us/stock/mirati-therapeutics-inc/accrued-royalties-current https://stock.noler.com/us/stock/mirati-therapeutics-inc/accumulated-depreciation https://stock.noler.com/us/stock/mirati-therapeutics-inc/additional-paid-in-capital https://stock.noler.com/us/stock/mirati-therapeutics-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/mirati-therapeutics-inc/amortization https://stock.noler.com/us/stock/mirati-therapeutics-inc/amortization-of-lease-incentives https://stock.noler.com/us/stock/mirati-therapeutics-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/mirati-therapeutics-inc/aoci https://stock.noler.com/us/stock/mirati-therapeutics-inc/asset-impairment-charges https://stock.noler.com/us/stock/mirati-therapeutics-inc/assets-fair-value-disclosure https://stock.noler.com/us/stock/mirati-therapeutics-inc/available-for-sale-accumulated-gross-unrealized-gain-before-tax https://stock.noler.com/us/stock/mirati-therapeutics-inc/available-for-sale-accumulated-gross-unrealized-loss-before-tax https://stock.noler.com/us/stock/mirati-therapeutics-inc/available-for-sale-amortized-cost https://stock.noler.com/us/stock/mirati-therapeutics-inc/available-for-sale-debt-accumulated-gross-unrealized-gain-before-tax https://stock.noler.com/us/stock/mirati-therapeutics-inc/available-for-sale-debt-accumulated-gross-unrealized-loss-before-tax https://stock.noler.com/us/stock/mirati-therapeutics-inc/available-for-sale-debt-allowance-for-credit-loss https://stock.noler.com/us/stock/mirati-therapeutics-inc/available-for-sale-debt-amortized-cost-basis https://stock.noler.com/us/stock/mirati-therapeutics-inc/available-for-sale-debt-gain-loss https://stock.noler.com/us/stock/mirati-therapeutics-inc/available-for-sale-debt-securities https://stock.noler.com/us/stock/mirati-therapeutics-inc/available-for-sale-securities https://stock.noler.com/us/stock/mirati-therapeutics-inc/basic-shares https://stock.noler.com/us/stock/mirati-therapeutics-inc/capital-expenditures https://stock.noler.com/us/stock/mirati-therapeutics-inc/capital-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/mirati-therapeutics-inc/cash-and-cash-equivalents-change https://stock.noler.com/us/stock/mirati-therapeutics-inc/cash-and-cash-equivalents-fair-value-disclosure https://stock.noler.com/us/stock/mirati-therapeutics-inc/cash-and-equivalents https://stock.noler.com/us/stock/mirati-therapeutics-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/mirati-therapeutics-inc/cash-flow-breakdown https://stock.noler.com/us/stock/mirati-therapeutics-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/mirati-therapeutics-inc/class-of-warrant-or-right-number-of-securities-called-by-warrants-or-rights https://stock.noler.com/us/stock/mirati-therapeutics-inc/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/mirati-therapeutics-inc/common-stock-capital-shares-reserved-for-future-issuance https://stock.noler.com/us/stock/mirati-therapeutics-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/mirati-therapeutics-inc/common-stock-value https://stock.noler.com/us/stock/mirati-therapeutics-inc/comprehensive-income https://stock.noler.com/us/stock/mirati-therapeutics-inc/contract-liability https://stock.noler.com/us/stock/mirati-therapeutics-inc/contract-with-customer-liability-cumulative-catch-up-adjustment-to-revenue-change-in-measure-of-progress https://stock.noler.com/us/stock/mirati-therapeutics-inc/contract-with-customer-liability-noncurrent https://stock.noler.com/us/stock/mirati-therapeutics-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/mirati-therapeutics-inc/current-assets https://stock.noler.com/us/stock/mirati-therapeutics-inc/current-federal-tax-expense-benefit https://stock.noler.com/us/stock/mirati-therapeutics-inc/current-foreign-tax-expense-benefit https://stock.noler.com/us/stock/mirati-therapeutics-inc/current-income-tax-expense-benefit https://stock.noler.com/us/stock/mirati-therapeutics-inc/current-liabilities https://stock.noler.com/us/stock/mirati-therapeutics-inc/current-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/mirati-therapeutics-inc/deferred-compensation-share-based-arrangements-liability-current https://stock.noler.com/us/stock/mirati-therapeutics-inc/deferred-costs https://stock.noler.com/us/stock/mirati-therapeutics-inc/deferred-rent-credit-current https://stock.noler.com/us/stock/mirati-therapeutics-inc/deferred-revenue-and-credits-current https://stock.noler.com/us/stock/mirati-therapeutics-inc/deferred-revenue-noncurrent https://stock.noler.com/us/stock/mirati-therapeutics-inc/deferred-revenue-recognized https://stock.noler.com/us/stock/mirati-therapeutics-inc/deferred-tax-assets-capital-loss-carryforwards https://stock.noler.com/us/stock/mirati-therapeutics-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/mirati-therapeutics-inc/deferred-tax-assets-inventory https://stock.noler.com/us/stock/mirati-therapeutics-inc/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/mirati-therapeutics-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/mirati-therapeutics-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/mirati-therapeutics-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/mirati-therapeutics-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/mirati-therapeutics-inc/deferred-tax-assets-tax-credit-carryforwards-research https://stock.noler.com/us/stock/mirati-therapeutics-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-reserves https://stock.noler.com/us/stock/mirati-therapeutics-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/mirati-therapeutics-inc/deferred-tax-liabilities-investments https://stock.noler.com/us/stock/mirati-therapeutics-inc/defined-contribution-plan-cost-recognized https://stock.noler.com/us/stock/mirati-therapeutics-inc/defined-contribution-plan-employer-matching-contribution-percent-of-match https://stock.noler.com/us/stock/mirati-therapeutics-inc/defined-contribution-plan-maximum-annual-contributions-per-employee-amount https://stock.noler.com/us/stock/mirati-therapeutics-inc/depreciation https://stock.noler.com/us/stock/mirati-therapeutics-inc/depreciation-and-amortization https://stock.noler.com/us/stock/mirati-therapeutics-inc/derivative-liabilities-current https://stock.noler.com/us/stock/mirati-therapeutics-inc/diluted-shares https://stock.noler.com/us/stock/mirati-therapeutics-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/mirati-therapeutics-inc/effect-of-exchange-rate-on-cash-and-restricted-cash https://stock.noler.com/us/stock/mirati-therapeutics-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/mirati-therapeutics-inc/eps https://stock.noler.com/us/stock/mirati-therapeutics-inc/eps-basic https://stock.noler.com/us/stock/mirati-therapeutics-inc/exchange-rate-effect-on-cash https://stock.noler.com/us/stock/mirati-therapeutics-inc/fair-value-adjustment-of-warrants https://stock.noler.com/us/stock/mirati-therapeutics-inc/fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/mirati-therapeutics-inc/fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/mirati-therapeutics-inc/fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/mirati-therapeutics-inc/fair-value-measurement-with-unobservable-inputs-reconciliation-liability-transfers-into-level https://stock.noler.com/us/stock/mirati-therapeutics-inc/fair-value-measurement-with-unobservable-inputs-reconciliations-recurring-basis-liability-value https://stock.noler.com/us/stock/mirati-therapeutics-inc/financing-cash-flow https://stock.noler.com/us/stock/mirati-therapeutics-inc/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/mirati-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-after-year-five https://stock.noler.com/us/stock/mirati-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-next-twelve-months https://stock.noler.com/us/stock/mirati-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-remainder-of-fiscal-year https://stock.noler.com/us/stock/mirati-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-year-five https://stock.noler.com/us/stock/mirati-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-year-four https://stock.noler.com/us/stock/mirati-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-year-three https://stock.noler.com/us/stock/mirati-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-year-two https://stock.noler.com/us/stock/mirati-therapeutics-inc/finite-lived-intangible-assets-gross https://stock.noler.com/us/stock/mirati-therapeutics-inc/finite-lived-intangible-assets-net https://stock.noler.com/us/stock/mirati-therapeutics-inc/foreign-currency-transaction-gain-loss-before-tax https://stock.noler.com/us/stock/mirati-therapeutics-inc/foreign-currency-transaction-gain-loss-unrealized https://stock.noler.com/us/stock/mirati-therapeutics-inc/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/mirati-therapeutics-inc/general-and-administrative-expense https://stock.noler.com/us/stock/mirati-therapeutics-inc/income-tax https://stock.noler.com/us/stock/mirati-therapeutics-inc/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/mirati-therapeutics-inc/income-tax-examination-penalties-and-interest-accrued https://stock.noler.com/us/stock/mirati-therapeutics-inc/income-taxes-paid https://stock.noler.com/us/stock/mirati-therapeutics-inc/income-taxes-receivable https://stock.noler.com/us/stock/mirati-therapeutics-inc/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/mirati-therapeutics-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/mirati-therapeutics-inc/increase-decrease-in-deferred-charges https://stock.noler.com/us/stock/mirati-therapeutics-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/mirati-therapeutics-inc/increase-decrease-in-operating-lease-liability https://stock.noler.com/us/stock/mirati-therapeutics-inc/increase-decrease-in-other-current-assets https://stock.noler.com/us/stock/mirati-therapeutics-inc/increase-decrease-in-other-noncurrent-assets https://stock.noler.com/us/stock/mirati-therapeutics-inc/increase-decrease-in-other-operating-assets https://stock.noler.com/us/stock/mirati-therapeutics-inc/increase-decrease-in-other-operating-liabilities https://stock.noler.com/us/stock/mirati-therapeutics-inc/increase-decrease-in-restricted-cash-and-investments https://stock.noler.com/us/stock/mirati-therapeutics-inc/increase-decrease-in-security-deposits https://stock.noler.com/us/stock/mirati-therapeutics-inc/incremental-common-shares-attributable-to-call-options-and-warrants https://stock.noler.com/us/stock/mirati-therapeutics-inc/insider-transactions-other https://stock.noler.com/us/stock/mirati-therapeutics-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/mirati-therapeutics-inc/insider-transactions-warrants https://stock.noler.com/us/stock/mirati-therapeutics-inc/insider-transactions-warrants/purchases https://stock.noler.com/us/stock/mirati-therapeutics-inc/insider-transactions-warrants/sales https://stock.noler.com/us/stock/mirati-therapeutics-inc/interest-and-other-income https://stock.noler.com/us/stock/mirati-therapeutics-inc/interest-receivable-current https://stock.noler.com/us/stock/mirati-therapeutics-inc/inventory https://stock.noler.com/us/stock/mirati-therapeutics-inc/inventory-finished-goods https://stock.noler.com/us/stock/mirati-therapeutics-inc/inventory-raw-materials https://stock.noler.com/us/stock/mirati-therapeutics-inc/inventory-work-in-process https://stock.noler.com/us/stock/mirati-therapeutics-inc/investing-cash-flow https://stock.noler.com/us/stock/mirati-therapeutics-inc/investment-income-amortization-of-premium https://stock.noler.com/us/stock/mirati-therapeutics-inc/investment-income-net-amortization-of-discount-and-premium https://stock.noler.com/us/stock/mirati-therapeutics-inc/investments-fair-value-disclosure https://stock.noler.com/us/stock/mirati-therapeutics-inc/lease-and-rental-expense https://stock.noler.com/us/stock/mirati-therapeutics-inc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/mirati-therapeutics-inc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/mirati-therapeutics-inc/level-3-asset-value https://stock.noler.com/us/stock/mirati-therapeutics-inc/license-and-services-revenue https://stock.noler.com/us/stock/mirati-therapeutics-inc/long-term-investments https://stock.noler.com/us/stock/mirati-therapeutics-inc/marketable-securities-current https://stock.noler.com/us/stock/mirati-therapeutics-inc/net-change-in-cash https://stock.noler.com/us/stock/mirati-therapeutics-inc/net-income https://stock.noler.com/us/stock/mirati-therapeutics-inc/net-income-loss-attributable-to-parent-diluted https://stock.noler.com/us/stock/mirati-therapeutics-inc/new-accounting-pronouncement-or-change-in-accounting-principle-cumulative-effect-of-change-on-equity-or-net-assets https://stock.noler.com/us/stock/mirati-therapeutics-inc/noncash-or-part-noncash-acquisition-intangible-assets-acquired https://stock.noler.com/us/stock/mirati-therapeutics-inc/number-of-operating-segments https://stock.noler.com/us/stock/mirati-therapeutics-inc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/mirati-therapeutics-inc/oci-unrealized-holding-gain-loss-on-securities-arising-net-of-tax https://stock.noler.com/us/stock/mirati-therapeutics-inc/operating-cash-flow https://stock.noler.com/us/stock/mirati-therapeutics-inc/operating-expenses https://stock.noler.com/us/stock/mirati-therapeutics-inc/operating-income https://stock.noler.com/us/stock/mirati-therapeutics-inc/operating-lease-assets https://stock.noler.com/us/stock/mirati-therapeutics-inc/operating-lease-cost https://stock.noler.com/us/stock/mirati-therapeutics-inc/operating-lease-liability https://stock.noler.com/us/stock/mirati-therapeutics-inc/operating-lease-liability-current https://stock.noler.com/us/stock/mirati-therapeutics-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/mirati-therapeutics-inc/operating-lease-payments-due https://stock.noler.com/us/stock/mirati-therapeutics-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/mirati-therapeutics-inc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/mirati-therapeutics-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/mirati-therapeutics-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/mirati-therapeutics-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/mirati-therapeutics-inc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/mirati-therapeutics-inc/operating-leases-future-minimum-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/mirati-therapeutics-inc/operating-leases-rent-expense-net https://stock.noler.com/us/stock/mirati-therapeutics-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/mirati-therapeutics-inc/other-accrued-liabilities-current-and-noncurrent https://stock.noler.com/us/stock/mirati-therapeutics-inc/other-current-assets https://stock.noler.com/us/stock/mirati-therapeutics-inc/other-current-liabilities https://stock.noler.com/us/stock/mirati-therapeutics-inc/other-liabilities https://stock.noler.com/us/stock/mirati-therapeutics-inc/other-liabilities-and-deferred-revenue-noncurrent https://stock.noler.com/us/stock/mirati-therapeutics-inc/other-marketable-securities-current https://stock.noler.com/us/stock/mirati-therapeutics-inc/other-marketable-securities-restricted-current https://stock.noler.com/us/stock/mirati-therapeutics-inc/other-noncurrent-assets https://stock.noler.com/us/stock/mirati-therapeutics-inc/other-noncurrent-liabilities https://stock.noler.com/us/stock/mirati-therapeutics-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/mirati-therapeutics-inc/other-nonrecurring-expense https://stock.noler.com/us/stock/mirati-therapeutics-inc/other-receivables-net-current https://stock.noler.com/us/stock/mirati-therapeutics-inc/paid-in-capital-other https://stock.noler.com/us/stock/mirati-therapeutics-inc/paid-in-capital-share-based-compensation-stock-options-requisite-service-period-recognition https://stock.noler.com/us/stock/mirati-therapeutics-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/mirati-therapeutics-inc/payments-for-restructuring https://stock.noler.com/us/stock/mirati-therapeutics-inc/payments-to-acquire-investments https://stock.noler.com/us/stock/mirati-therapeutics-inc/payments-to-acquire-short-term-investments https://stock.noler.com/us/stock/mirati-therapeutics-inc/preferred-shares-facts https://stock.noler.com/us/stock/mirati-therapeutics-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/mirati-therapeutics-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/mirati-therapeutics-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/mirati-therapeutics-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/mirati-therapeutics-inc/preferred-stock-value https://stock.noler.com/us/stock/mirati-therapeutics-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/mirati-therapeutics-inc/prepaid-expense-current https://stock.noler.com/us/stock/mirati-therapeutics-inc/pretax-income https://stock.noler.com/us/stock/mirati-therapeutics-inc/proceeds-from-issuance-of-shares-under-incentive-and-share-based-compensation-plans https://stock.noler.com/us/stock/mirati-therapeutics-inc/proceeds-from-issuance-of-shares-under-incentive-and-share-based-compensation-plans-including-stock-options https://stock.noler.com/us/stock/mirati-therapeutics-inc/proceeds-from-issuance-of-warrants https://stock.noler.com/us/stock/mirati-therapeutics-inc/proceeds-from-payments-for-other-financing-activities https://stock.noler.com/us/stock/mirati-therapeutics-inc/proceeds-from-sale-maturity-and-collections-of-investments https://stock.noler.com/us/stock/mirati-therapeutics-inc/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/mirati-therapeutics-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/mirati-therapeutics-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/mirati-therapeutics-inc/proceeds-from-stock-plans https://stock.noler.com/us/stock/mirati-therapeutics-inc/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/mirati-therapeutics-inc/property-plant-and-equipment-disposals https://stock.noler.com/us/stock/mirati-therapeutics-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/mirati-therapeutics-inc/property-plant-equipment https://stock.noler.com/us/stock/mirati-therapeutics-inc/public-float https://stock.noler.com/us/stock/mirati-therapeutics-inc/research-and-development https://stock.noler.com/us/stock/mirati-therapeutics-inc/restricted-cash https://stock.noler.com/us/stock/mirati-therapeutics-inc/restricted-cash-and-cash-equivalents https://stock.noler.com/us/stock/mirati-therapeutics-inc/restricted-cash-and-cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/mirati-therapeutics-inc/restricted-cash-and-investments-current https://stock.noler.com/us/stock/mirati-therapeutics-inc/restricted-cash-and-investments-noncurrent https://stock.noler.com/us/stock/mirati-therapeutics-inc/restricted-cash-noncurrent https://stock.noler.com/us/stock/mirati-therapeutics-inc/restructuring-and-related-cost-number-of-positions-eliminated-period-percent https://stock.noler.com/us/stock/mirati-therapeutics-inc/restructuring-charges https://stock.noler.com/us/stock/mirati-therapeutics-inc/restructuring-costs https://stock.noler.com/us/stock/mirati-therapeutics-inc/restructuring-reserve https://stock.noler.com/us/stock/mirati-therapeutics-inc/retained-earnings https://stock.noler.com/us/stock/mirati-therapeutics-inc/revenue https://stock.noler.com/us/stock/mirati-therapeutics-inc/revenue-from-contract-with-customer-excluding-assessed-tax https://stock.noler.com/us/stock/mirati-therapeutics-inc/revenue-from-contract-with-customer-including-assessed-tax https://stock.noler.com/us/stock/mirati-therapeutics-inc/right-of-use-asset-obtained-in-exchange-for-operating-lease-liability https://stock.noler.com/us/stock/mirati-therapeutics-inc/sale-of-stock-consideration-received-on-transaction https://stock.noler.com/us/stock/mirati-therapeutics-inc/sale-of-stock-number-of-shares-issued-in-transaction https://stock.noler.com/us/stock/mirati-therapeutics-inc/sale-of-stock-price-per-share https://stock.noler.com/us/stock/mirati-therapeutics-inc/security-deposit https://stock.noler.com/us/stock/mirati-therapeutics-inc/sga-expense https://stock.noler.com/us/stock/mirati-therapeutics-inc/share-price https://stock.noler.com/us/stock/mirati-therapeutics-inc/shareholders-equity https://stock.noler.com/us/stock/mirati-therapeutics-inc/shares-authorized https://stock.noler.com/us/stock/mirati-therapeutics-inc/shares-issued https://stock.noler.com/us/stock/mirati-therapeutics-inc/shares-issued-price-per-share https://stock.noler.com/us/stock/mirati-therapeutics-inc/shares-issued-shares-new-issues https://stock.noler.com/us/stock/mirati-therapeutics-inc/stock-and-warrants-issued-value-preferred-stock-and-warrants https://stock.noler.com/us/stock/mirati-therapeutics-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/mirati-therapeutics-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/mirati-therapeutics-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/mirati-therapeutics-inc/stock-award-fair-value-assumptions-weighted-average-volatility-rate https://stock.noler.com/us/stock/mirati-therapeutics-inc/stock-award-number-of-shares-available-for-grant https://stock.noler.com/us/stock/mirati-therapeutics-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/mirati-therapeutics-inc/stock-award-options-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/mirati-therapeutics-inc/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/mirati-therapeutics-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/mirati-therapeutics-inc/stock-based-compensation https://stock.noler.com/us/stock/mirati-therapeutics-inc/stock-compensation-allocation-of-recognized-period-costs-capitalized-amount https://stock.noler.com/us/stock/mirati-therapeutics-inc/stock-compensation-cash-received-from-exercise-of-stock-options https://stock.noler.com/us/stock/mirati-therapeutics-inc/stock-compensation-tax-benefit-from-compensation-expense https://stock.noler.com/us/stock/mirati-therapeutics-inc/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/mirati-therapeutics-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/mirati-therapeutics-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/mirati-therapeutics-inc/stock-issued-shares-issued-shares-conversion-of-convertible-securities https://stock.noler.com/us/stock/mirati-therapeutics-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/mirati-therapeutics-inc/stock-issued-shares-issued-value-employee-benefit-plan https://stock.noler.com/us/stock/mirati-therapeutics-inc/stock-issued-shares-issued-value-espp https://stock.noler.com/us/stock/mirati-therapeutics-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/mirati-therapeutics-inc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/mirati-therapeutics-inc/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/mirati-therapeutics-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/mirati-therapeutics-inc/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/mirati-therapeutics-inc/stock-options-expirations-in-period https://stock.noler.com/us/stock/mirati-therapeutics-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/mirati-therapeutics-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/mirati-therapeutics-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/mirati-therapeutics-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/mirati-therapeutics-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/mirati-therapeutics-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/mirati-therapeutics-inc/stock-options-vested-and-expected-to-vest-outstanding-aggregate-intrinsic-value https://stock.noler.com/us/stock/mirati-therapeutics-inc/stock-options-vested-and-expected-to-vest-outstanding-average-exercise-price https://stock.noler.com/us/stock/mirati-therapeutics-inc/stock-options-vested-and-expected-to-vest-outstanding-number https://stock.noler.com/us/stock/mirati-therapeutics-inc/stock-options-vested-in-period-fair-value https://stock.noler.com/us/stock/mirati-therapeutics-inc/tax-rate-reconciliation-share-based-compensation-excess-tax-benefit-amount https://stock.noler.com/us/stock/mirati-therapeutics-inc/tax-rate-reconciliation-tax-cuts-and-jobs-act-amount https://stock.noler.com/us/stock/mirati-therapeutics-inc/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/mirati-therapeutics-inc/tax-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/mirati-therapeutics-inc/tax-reconciliation-disposition-of-business https://stock.noler.com/us/stock/mirati-therapeutics-inc/tax-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/mirati-therapeutics-inc/tax-reconciliation-nondeductible-expense-other https://stock.noler.com/us/stock/mirati-therapeutics-inc/tax-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/mirati-therapeutics-inc/tax-reconciliation-other-adjustments https://stock.noler.com/us/stock/mirati-therapeutics-inc/tax-reconciliation-other-reconciling-items https://stock.noler.com/us/stock/mirati-therapeutics-inc/tax-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/mirati-therapeutics-inc/tax-reconciliation-tax-contingencies https://stock.noler.com/us/stock/mirati-therapeutics-inc/tax-reconciliation-tax-credits https://stock.noler.com/us/stock/mirati-therapeutics-inc/total-assets https://stock.noler.com/us/stock/mirati-therapeutics-inc/total-contract-liability https://stock.noler.com/us/stock/mirati-therapeutics-inc/total-liabilities https://stock.noler.com/us/stock/mirati-therapeutics-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/mirati-therapeutics-inc/trading-securities https://stock.noler.com/us/stock/mirati-therapeutics-inc/trading-securities-cost https://stock.noler.com/us/stock/mirati-therapeutics-inc/trading-securities-current https://stock.noler.com/us/stock/mirati-therapeutics-inc/trading-securities-restricted https://stock.noler.com/us/stock/mirati-therapeutics-inc/unrealized-gain-loss-on-investments https://stock.noler.com/us/stock/mirati-therapeutics-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/mirati-therapeutics-inc/warrants-and-rights-outstanding https://stock.noler.com/us/stock/mirati-therapeutics-inc/weighted-average-number-of-share-outstanding-basic-and-diluted